Suppr超能文献

阿霉素类抗生素巴龙霉素抑制利什曼原虫核糖体的原子分辨率快照。

Atomic resolution snapshot of Leishmania ribosome inhibition by the aminoglycoside paromomycin.

机构信息

Faculty of Chemistry, Department of Structural Biology, Weizmann Institute of Science, Rehovot, 761001, Israel.

Departments of Molecular and Cellular Physiology, and Structural Biology, Stanford University School of Medicine, Stanford, CA, 94305, USA.

出版信息

Nat Commun. 2017 Nov 17;8(1):1589. doi: 10.1038/s41467-017-01664-4.

Abstract

Leishmania is a single-celled eukaryotic parasite afflicting millions of humans worldwide, with current therapies limited to a poor selection of drugs that mostly target elements in the parasite's cell envelope. Here we determined the atomic resolution electron cryo-microscopy (cryo-EM) structure of the Leishmania ribosome in complex with paromomycin (PAR), a highly potent compound recently approved for treatment of the fatal visceral leishmaniasis (VL). The structure reveals the mechanism by which the drug induces its deleterious effects on the parasite. We further show that PAR interferes with several aspects of cytosolic translation, thus highlighting the cytosolic rather than the mitochondrial ribosome as the primary drug target. The results also highlight unique as well as conserved elements in the PAR-binding pocket that can serve as hotspots for the development of novel therapeutics.

摘要

利什曼原虫是一种单细胞真核寄生虫,感染了全球数百万人,目前的治疗方法仅限于少数几种药物,这些药物主要针对寄生虫细胞包膜中的元素。在这里,我们确定了与帕罗霉素(PAR)复合的利什曼核糖体的原子分辨率电子冷冻电镜(cryo-EM)结构,PAR 是一种最近被批准用于治疗致命内脏利什曼病(VL)的高活性化合物。该结构揭示了药物对寄生虫产生有害影响的机制。我们进一步表明,PAR 干扰了细胞质翻译的几个方面,因此突出了细胞质核糖体而不是线粒体核糖体作为主要的药物靶点。研究结果还突出了 PAR 结合口袋中独特且保守的元素,这些元素可以作为开发新型治疗药物的热点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c2a/5693986/ea774df916f2/41467_2017_1664_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验